US.DVA · DaVita

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.667940876656473,
        "turnoverUsdM": 126.031032,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.DVA",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 222.8772,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 1,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 5.3,
      "take_profit_price": 247.212,
      "target_multiplier": 1.6,
      "technical_strength": 1.38,
      "take_profit_percent": 5
    },
    "positionPoints": 1.4,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.335881753312946,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 52.3,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 51.3,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 1
  },
  "market": {
    "ma20": 231.4465,
    "ma50": 212.6414,
    "close": 235.44,
    "prevClose": 234.27,
    "avgVolume20": 764730,
    "volumeRatio": 0.7,
    "changePercent": 0.5
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 1,
    "details": {
      "ret_5d": -0.0064565134827193615,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 1,
      "vcp_bonus": 0,
      "vol_ratio": 0.6843037117052624,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 1.0308974337718264,
      "volat_points": 0,
      "day_range_pct": 0.028245030581039793,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 52.3,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 1.3,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 26,
        "contribution": 1.3
      },
      {
        "raw": 10.8,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 54,
        "contribution": 10.8
      },
      {
        "raw": 8.8,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 58.67,
        "contribution": 8.8
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.6,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 66,
        "contribution": 6.6
      },
      {
        "raw": 18.8,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 62.67,
        "contribution": 18.8
      },
      {
        "raw": 3,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 30,
        "contribution": 3
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 51.3,
    "details": [
      "基本面分析總分: 1.3/5分",
      "資金流分析總分: 10.8/20分",
      "市場環境分析總分: 8.8/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.6/10分",
      "技術信號分析總分: 18.8/30分",
      "情緒分析: 3/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 1.3,
      "資金流": 10.8,
      "市場環境": 8.8,
      "情緒分析": 3,
      "技術信號": 18.8,
      "風險管理": 6.6
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0,
          "pePoints": 0.4,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0,
          "marginPoints": 0,
          "turnoverUsdM": 126.031032,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0,
          "marketCapPoints": 0.4
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 2.4,
          "mfiPoints": 0.8,
          "obvPoints": 1.6,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.DVA",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 18.7
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 711.71300025,
                "ma50": 718.2872022,
                "name": "QQQ",
                "close": 684.22998,
                "points": 0.4
              },
              "spy": {
                "ma20": 746.1530053500001,
                "ma50": 745.0680014400001,
                "name": "SPY",
                "close": 738.92999,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.667940876656473,
          "atrPoints": 3,
          "cciPoints": 3.2,
          "vixPoints": 1.8,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 3,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 1,
              "sentimentScoreRaw": 0.3
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140995074,
                "url": "https://finnhub.io/api/news?id=2e3a47d91153d28b9b67dd4c029024e3626b28c9ad8c357cea13d3fbe9037847",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Moon Capital Management, LLC, an investment management company, released its second quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 index rebounded in the second quarter, achieving a 9.6% return for the first half of the year, while Moon Capital Management’s equity portfolio gained 4%. AI-related stocks led […]",
                "category": "company",
                "datetime": 1784817203,
                "headline": "Moon Capital Management Exited DaVita (DVA) with 174% total Return"
              },
              {
                "id": 140939305,
                "url": "https://finnhub.io/api/news?id=15ac27ede822ffec0e8dec40701b723d6df00aed02d2c42729aa2a05cacefd43",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita HealthCare (DVA) reached $236.97 at the closing of the latest trading day, reflecting a +1.26% change compared to its last close.",
                "category": "company",
                "datetime": 1784325607,
                "headline": "DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors"
              },
              {
                "id": 140927466,
                "url": "https://finnhub.io/api/news?id=cc6407477786d13b4c47e5d8d894ec56c9a407f0925131efb1224e8965782f46",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $234.01, denoting a +1.04% move from the preceding trading day.",
                "category": "company",
                "datetime": 1784240104,
                "headline": "DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts"
              },
              {
                "id": 140867052,
                "url": "https://finnhub.io/api/news?id=e152ec756aace3bba58f31a5ce7ae17c139c354610a150c1a6ae283a0dae2912",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $232.8, denoting a +1.45% move from the preceding trading day.",
                "category": "company",
                "datetime": 1783720805,
                "headline": "DaVita HealthCare (DVA) Laps the Stock Market: Here's Why"
              },
              {
                "id": 140846456,
                "url": "https://finnhub.io/api/news?id=c38bcca38ca8675078b3be3b4842da8d201fbc3572b18e0e85e9d24128177a42",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita HealthCare (DVA) reached $230.72 at the closing of the latest trading day, reflecting a -1.53% change compared to its last close.",
                "category": "company",
                "datetime": 1783548905,
                "headline": "DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights"
              },
              {
                "id": 140804348,
                "url": "https://finnhub.io/api/news?id=6527c9645aa5d0ae7ce2b8aba19c821b75610b3af29ca6ebc9a05c8dcc17e770",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita stock has delivered a 126.1% return over the past three years, yet valuation checks send mixed signals, with a Discounted Cash Flow (DCF) estimate pointing to a premium while market multiples suggest the shares may still be on the cheap side. DaVita's 126.1% three year return highlights how strongly the stock has rewarded investors who stayed invested over a multi year horizon. Expansion of DaVita's AI driven Integrated Kidney Care platform can support expectations for future cash...",
                "category": "company",
                "datetime": 1783135172,
                "headline": "DaVita (DVA) Stock Could Be 19% Overvalued Despite Strong Q1 Results"
              },
              {
                "id": 140803808,
                "url": "https://finnhub.io/api/news?id=949d5fc3873983f82469989bd63578468c2ce96f790fc970c92ffb26238236d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Is DVA a good stock to buy? We came across a bullish thesis on DaVita Inc. on StockCompass’s Substack. In this article, we will summarize the bulls’ thesis on DVA. DaVita Inc.’s share was trading at $228.03 as of July 1st. DVA’s trailing and forward P/E were 21.43 and 15.34 respectively according to Yahoo Finance. DaVita Inc. […]",
                "category": "company",
                "datetime": 1783119646,
                "headline": "Is DaVita Inc. (DVA) A Good Stock To Buy Now?"
              },
              {
                "id": 140797868,
                "url": "https://finnhub.io/api/news?id=12474eb91db08dc3f83c45c9bb9bb1bfaee4ed1b73857b44a6c42ab6133f75d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita (NYSE:DVA) is expanding its Integrated Kidney Care platform, adding new capabilities aimed at value-based kidney care delivery. The company is rolling out AI-powered health technologies, including an AI-driven scheduling tool for dialysis care. These updates focus on improving care coordination, patient experience, and operational efficiency across DaVita's network. DaVita enters this phase of product and care model expansion with its stock at $234.91 and a value score of 3. The...",
                "category": "company",
                "datetime": 1783062569,
                "headline": "DaVita (DVA) Expands Integrated Kidney Care With AI Tools For Dialysis Care"
              }
            ],
            "raw_source": [
              {
                "id": 141013951,
                "url": "https://finnhub.io/api/news?id=fc11597c6346c291a7b659239030f6981c74d9757be3c5c75a0d6650221c1b9e",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1323206885/image_1323206885.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DVA",
                "summary": "DaVita (DVA) nears the high end of its historical valuation range, signaling possible overvaluation and mean reversion risk—monitor levels and consider...",
                "category": "company",
                "datetime": 1784942311,
                "headline": "Davita: Valuation Is Nearing Resistance Level"
              },
              {
                "id": 140995074,
                "url": "https://finnhub.io/api/news?id=2e3a47d91153d28b9b67dd4c029024e3626b28c9ad8c357cea13d3fbe9037847",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Moon Capital Management, LLC, an investment management company, released its second quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 index rebounded in the second quarter, achieving a 9.6% return for the first half of the year, while Moon Capital Management’s equity portfolio gained 4%. AI-related stocks led […]",
                "category": "company",
                "datetime": 1784817203,
                "headline": "Moon Capital Management Exited DaVita (DVA) with 174% total Return"
              },
              {
                "id": 140976595,
                "url": "https://finnhub.io/api/news?id=89e110550952c9e15b4507d5306b7b721ede492c9613b6d9bbb958f4ccd0fa50",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 4, 2026, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.",
                "category": "company",
                "datetime": 1784667600,
                "headline": "DaVita Inc. Schedules 2nd Quarter 2026 Investor Conference Call"
              },
              {
                "id": 140970660,
                "url": "https://finnhub.io/api/news?id=a4b627a8b733a40b37e7f7eae0dc8601667f5fa49da3fce75976aa0a5246b6d4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.",
                "category": "company",
                "datetime": 1784636066,
                "headline": "3 S&P 500 Stocks We Think Twice About"
              },
              {
                "id": 140939305,
                "url": "https://finnhub.io/api/news?id=15ac27ede822ffec0e8dec40701b723d6df00aed02d2c42729aa2a05cacefd43",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita HealthCare (DVA) reached $236.97 at the closing of the latest trading day, reflecting a +1.26% change compared to its last close.",
                "category": "company",
                "datetime": 1784325607,
                "headline": "DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors"
              },
              {
                "id": 140930883,
                "url": "https://finnhub.io/api/news?id=3f3323cac288baf1f5384f9824b7d82f6bb68ee9951ef53984b98c2ce408b41e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.",
                "category": "company",
                "datetime": 1784286346,
                "headline": "3 Profitable Stocks We Think Twice About"
              },
              {
                "id": 140930419,
                "url": "https://finnhub.io/api/news?id=a635d42d7e9ba844765bebc179c919fed8652abbb81b6c4c6fa8dc3862caa0f9",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2224096544/image_2224096544.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DVA",
                "summary": "Unfortunately, DaVita’s growth algorithm has become more challenging. After decades of expansion, total dialysis treatment volume has been roughly flat for the past six years.",
                "category": "company",
                "datetime": 1784270640,
                "headline": "DaVita: Why We Exited Our Position In Q2"
              },
              {
                "id": 140927466,
                "url": "https://finnhub.io/api/news?id=cc6407477786d13b4c47e5d8d894ec56c9a407f0925131efb1224e8965782f46",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $234.01, denoting a +1.04% move from the preceding trading day.",
                "category": "company",
                "datetime": 1784240104,
                "headline": "DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts"
              },
              {
                "id": 140910210,
                "url": "https://finnhub.io/api/news?id=e85d3400ce996fa4fa32383d4c6bdf2bc2d18e773a2481aad50735dd6f1f4365",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1421088347/image_1421088347.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DVA",
                "summary": "DaVita Inc. stock doubled on a Q1 '26 beat and court win, but valuation looks stretched vs. fair value. Click for this DVA update and see if it is right for you.",
                "category": "company",
                "datetime": 1784117670,
                "headline": "DaVita: I Believe This Is Overvalued"
              },
              {
                "id": 140910011,
                "url": "https://finnhub.io/api/news?id=2c406dcdc41760e5e4c2dd9ff5258672503d1236f6da41b0c4254f62a8287caf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita is entering earnings with strong momentum as investors look for another quarter of solid execution.",
                "category": "company",
                "datetime": 1784104257,
                "headline": "What You Need To Know Ahead of DaVita’s Earnings Release"
              },
              {
                "id": 140896094,
                "url": "https://finnhub.io/api/news?id=444721f26be6039adde19cf99644ba828e3405f2b1686dc7955fe51c77e2b8c2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.",
                "category": "company",
                "datetime": 1784026511,
                "headline": "3 Unpopular Stocks Walking a Fine Line"
              },
              {
                "id": 140901238,
                "url": "https://finnhub.io/api/news?id=426851a614c229f3f5ec69a0f8e9914da95a173361434696e2a5dc5e78e2433e",
                "image": "",
                "source": "Benzinga",
                "related": "DVA",
                "summary": "Truist Securities  analyst David Macdonald   maintains DaVita (NYSE:DVA) with a Hold and raises the price target from $205 to $250.",
                "category": "company",
                "datetime": 1784021419,
                "headline": "Truist Securities Maintains Hold on DaVita, Raises Price Target to $250"
              },
              {
                "id": 140867052,
                "url": "https://finnhub.io/api/news?id=e152ec756aace3bba58f31a5ce7ae17c139c354610a150c1a6ae283a0dae2912",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $232.8, denoting a +1.45% move from the preceding trading day.",
                "category": "company",
                "datetime": 1783720805,
                "headline": "DaVita HealthCare (DVA) Laps the Stock Market: Here's Why"
              },
              {
                "id": 140866550,
                "url": "https://finnhub.io/api/news?id=db82d130dbc51f82b030b324b1ab99cdfdd3268da58c3354be593dca905cfbf7",
                "image": "",
                "source": "Benzinga",
                "related": "DVA",
                "summary": "UBS  analyst A.J. Rice   maintains DaVita (NYSE:DVA) with a Buy and raises the price target from $235 to $270.",
                "category": "company",
                "datetime": 1783689348,
                "headline": "UBS Maintains Buy on DaVita, Raises Price Target to $270"
              },
              {
                "id": 140856580,
                "url": "https://finnhub.io/api/news?id=5e0cdd5c3b45088f22d617c0e07c5e83b921b663854de12c8600bb3629ee0f5c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Don't underestimate Ted Weschler's role in the post-Buffett era.",
                "category": "company",
                "datetime": 1783637400,
                "headline": "Everyone Is Watching Greg Abel. But Another Berkshire Hathaway Stock Picker Is Quietly Winning in 2026."
              },
              {
                "id": 140852002,
                "url": "https://finnhub.io/api/news?id=1a61697a3ce4b5e855140a4d96c7b4924aa1f8c7d125fea6d9206353edcbbb83",
                "image": "",
                "source": "Benzinga",
                "related": "DVA",
                "summary": "Barclays  analyst Andrew Mok   maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price target from $194 to $218.",
                "category": "company",
                "datetime": 1783589536,
                "headline": "Barclays Maintains Equal-Weight on DaVita, Raises Price Target to $218"
              },
              {
                "id": 140846456,
                "url": "https://finnhub.io/api/news?id=c38bcca38ca8675078b3be3b4842da8d201fbc3572b18e0e85e9d24128177a42",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita HealthCare (DVA) reached $230.72 at the closing of the latest trading day, reflecting a -1.53% change compared to its last close.",
                "category": "company",
                "datetime": 1783548905,
                "headline": "DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights"
              },
              {
                "id": 140804348,
                "url": "https://finnhub.io/api/news?id=6527c9645aa5d0ae7ce2b8aba19c821b75610b3af29ca6ebc9a05c8dcc17e770",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita stock has delivered a 126.1% return over the past three years, yet valuation checks send mixed signals, with a Discounted Cash Flow (DCF) estimate pointing to a premium while market multiples suggest the shares may still be on the cheap side. DaVita's 126.1% three year return highlights how strongly the stock has rewarded investors who stayed invested over a multi year horizon. Expansion of DaVita's AI driven Integrated Kidney Care platform can support expectations for future cash...",
                "category": "company",
                "datetime": 1783135172,
                "headline": "DaVita (DVA) Stock Could Be 19% Overvalued Despite Strong Q1 Results"
              },
              {
                "id": 140803808,
                "url": "https://finnhub.io/api/news?id=949d5fc3873983f82469989bd63578468c2ce96f790fc970c92ffb26238236d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Is DVA a good stock to buy? We came across a bullish thesis on DaVita Inc. on StockCompass’s Substack. In this article, we will summarize the bulls’ thesis on DVA. DaVita Inc.’s share was trading at $228.03 as of July 1st. DVA’s trailing and forward P/E were 21.43 and 15.34 respectively according to Yahoo Finance. DaVita Inc. […]",
                "category": "company",
                "datetime": 1783119646,
                "headline": "Is DaVita Inc. (DVA) A Good Stock To Buy Now?"
              },
              {
                "id": 140802433,
                "url": "https://finnhub.io/api/news?id=62723bd3c7a9defce0d3ae2513b6b9539026160175ddd370ab9c4da81406ba8d",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DVA",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1783085724,
                "headline": "8 Health Care Stocks Whale Activity In Today’s Session"
              },
              {
                "id": 140799713,
                "url": "https://finnhub.io/api/news?id=96c8eb4fad145b35204f7ffd3b84e55c0b65ee1b8d74bee1f0fd6eb6b6d913da",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "ADM, CASY, DVA, CVS and BEN top a list of five non-AI S&P 500 stocks that surged more than 30% in 1H 2026 and still show momentum for 2H.",
                "category": "company",
                "datetime": 1783081680,
                "headline": "Top 5 Non-AI S&P 500 Stock Picks for 2H 2026 That Have Surged in 1H"
              },
              {
                "id": 140797868,
                "url": "https://finnhub.io/api/news?id=12474eb91db08dc3f83c45c9bb9bb1bfaee4ed1b73857b44a6c42ab6133f75d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita (NYSE:DVA) is expanding its Integrated Kidney Care platform, adding new capabilities aimed at value-based kidney care delivery. The company is rolling out AI-powered health technologies, including an AI-driven scheduling tool for dialysis care. These updates focus on improving care coordination, patient experience, and operational efficiency across DaVita's network. DaVita enters this phase of product and care model expansion with its stock at $234.91 and a value score of 3. The...",
                "category": "company",
                "datetime": 1783062569,
                "headline": "DaVita (DVA) Expands Integrated Kidney Care With AI Tools For Dialysis Care"
              },
              {
                "id": 140791636,
                "url": "https://finnhub.io/api/news?id=661e97cd43e0d06f50ac50f6cba6e3f01c49c9e2381632edd55a9ecb153ed3bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
                "category": "company",
                "datetime": 1782999604,
                "headline": "Should Value Investors Buy DaVita (DVA) Stock?"
              },
              {
                "id": 140791637,
                "url": "https://finnhub.io/api/news?id=20bf4e6b018e94f0380de99a31b0dd6ef82e36355173b9eaaa2cce309df00cd6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "The Pennant Group (PNTG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
                "category": "company",
                "datetime": 1782998103,
                "headline": "The Pennant Group, Inc. (PNTG) Soars to 52-Week High, Time to Cash Out?"
              },
              {
                "id": 140788397,
                "url": "https://finnhub.io/api/news?id=432c747e3e810d6f141443f49217328be965b2f8b452d40812811020722add0b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DVA, FIVE, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 2, 2026.",
                "category": "company",
                "datetime": 1782975300,
                "headline": "Best Growth Stocks to Buy for July 2nd"
              },
              {
                "id": 140775244,
                "url": "https://finnhub.io/api/news?id=b69db6c2c9a010741a4bb83558e5cee4689a325960ea48679f822615682cf8b0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Weschler is responsible for running about 6% of Berkshire’s equity portfolio of more than $300 billion.",
                "category": "company",
                "datetime": 1782852240,
                "headline": "Berkshire Manager Weschler May Be Having A Good Year Due to DaVita, Sirius Holdings"
              },
              {
                "id": 140773882,
                "url": "https://finnhub.io/api/news?id=3a0c6820523991f2ac98879a6c2e162a1c12042308237a2506a31c58a4be32e9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita Inc. (NYSE:DVA) is one of the 10 Best Long-Term Stocks to Buy Now According to Warren Buffett. DaVita Inc. (NYSE:DVA) is a healthcare company that caters to the needs of people suffering from kidney ailments. Another long-term Warren Buffet stock pick, Berkshire first disclosed a stake in the firm in the fourth quarter of […]",
                "category": "company",
                "datetime": 1782840678,
                "headline": "Warren Buffett’s Berkshire Hathaway Has Held DaVita Inc. (DVA) Since 2011"
              },
              {
                "id": 140774660,
                "url": "https://finnhub.io/api/news?id=c53acafca2638a046acd5a83f798bb2bc1ecf66c47699e1716102c5c673932ad",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DVA is advancing kidney care through IKC expansion, CMS CKCC progress and AI-driven dialysis scheduling improvements.",
                "category": "company",
                "datetime": 1782839220,
                "headline": "DaVita Stock Benefits From Strengthening Kidney Care Delivery"
              },
              {
                "id": 140771210,
                "url": "https://finnhub.io/api/news?id=4c45daee4c4c7888c7fbc07058faba19dc186013f117a5d9db6f76d8ed81e54e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DVA, FIVE, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 30, 2026.",
                "category": "company",
                "datetime": 1782808020,
                "headline": "Best Growth Stocks to Buy for June 30th"
              },
              {
                "id": 140762816,
                "url": "https://finnhub.io/api/news?id=21bddf32f8e1e2b56da97312af52e63165e1a8f37b38e7507248f742cd302aba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Here is how Alignment Healthcare (ALHC) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1782740404,
                "headline": "Is Alignment Healthcare (ALHC) Stock Outpacing Its Medical Peers This Year?"
              },
              {
                "id": 140741781,
                "url": "https://finnhub.io/api/news?id=4588c5ee5b30f81df0bbbca0974d66723c188694c9d873e5b48ac36e8f316820",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "In the most recent trading session, DaVita HealthCare (DVA) closed at $217.04, indicating a +1.72% shift from the previous trading day.",
                "category": "company",
                "datetime": 1782511206,
                "headline": "Why the Market Dipped But DaVita HealthCare (DVA) Gained Today"
              },
              {
                "id": 140736705,
                "url": "https://finnhub.io/api/news?id=b55da5f2dd35567c8e181c74eb3a801d8b9d602cc099e0f8126e68472465d058",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
                "category": "company",
                "datetime": 1782481204,
                "headline": "Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?"
              },
              {
                "id": 140734710,
                "url": "https://finnhub.io/api/news?id=4024868e7b2f26fb5d4be49384744fd4d82d0fde97715190bef02f8b7ffd2fda",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Analysts don't like to put \"sell\" ratings on S&P 500 stocks. So the fact they're willing to do it with some is worth your attention.",
                "category": "company",
                "datetime": 1782472359,
                "headline": "If You Own These 10 Stocks — Analysts Think You Should Sell Them"
              },
              {
                "id": 140734119,
                "url": "https://finnhub.io/api/news?id=51c7d454f29a841f4b7711041b955c456aa16ecca97f9ecaecf387dec41d1f0f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "LYB, HRB and DVA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 26th, 2026.",
                "category": "company",
                "datetime": 1782462540,
                "headline": "Best Growth Stocks to Buy for June 26th"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.3,
            "source_article_count": 34,
            "discarded_article_count": 23
          },
          "sentimentPoints": 3
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 18.8,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 1.7999999999999998,
          "vcpPoints": 2.2,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.2,
            "vcp_reason": "波幅收縮(18%→6.1%)；跌縮量(近10日3日)；站上MA50；Ready=Y；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 795223.3333333334,
              "down_days": 4,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 631330,
              "avg_vol_20": 782255,
              "avg_vol_30": 795223.3333333334,
              "range_pct_10": 0.060609921848454006,
              "range_pct_20": 0.13820926775399248,
              "range_pct_30": 0.18038566089024805,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.7939027610692174,
              "dist_to_20d_high": 0.01752628943415118,
              "down_shrink_days": 3,
              "breakout_level_20d": 239.64,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.33600188368259976
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.8,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.667940876656473,
              "turnoverUsdM": 126.031032,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.DVA",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 222.8772,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 1,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 5.3,
            "take_profit_price": 247.212,
            "target_multiplier": 1.6,
            "technical_strength": 1.38,
            "take_profit_percent": 5
          },
          "positionPoints": 1.4,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.335881753312946,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 6.2814,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.67
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "適中偏強",
      "score": 8,
      "value": 53.93
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "輕微流入",
      "score": 6,
      "value": 0.1922
    },
    "kdj": {
      "d": 68.01,
      "j": 70.05,
      "k": 68.69,
      "rule": "Cursor_18.24 K/D cross",
      "score": 6,
      "signal": "強金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 38.99
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 4,
      "trend": "弱勢",
      "value": 16863100,
      "recentSlope": -14700,
      "previousSlope": 319390
    },
    "rsi": 49.63,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 6,
      "trend": "下降",
      "value": 235.8971,
      "position": "SAR接近價",
      "distancePct": 0.19,
      "previousTrend": "下降"
    },
    "ma50": 212.6414,
    "macd": {
      "macd": 7.047776509167846,
      "trend": "中性偏多",
      "signal": 8.21875952708174,
      "histogram": -1.170983017913894
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 229.8194,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 32
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.7,
      "score": 2,
      "avgVolume": 764730,
      "currentVolume": 535300
    },
    "derived": {
      "ma20": 231.4465,
      "ma50": 212.6414,
      "prevClose": 234.27,
      "avgVolume10": 607310,
      "avgVolume20": 764730,
      "changePercent": 0.5,
      "avgVolumeForScore": 764730
    },
    "ma_cross": {
      "ma20": 231.4465,
      "ma50": 212.6414,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 230.3425,
      "prevMa50": 211.9434,
      "spreadPct": 8.84,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 220.4673,
      "upper": 242.4257,
      "position": "上半部"
    },
    "rsi_short": 54.07,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.7
    }
  }
}

{
  "close": 235.44,
  "volume": 535300,
  "changePercent": 0.5
}